Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy-Reference-Cited by-同舟云学术

Mex3a marks drug-tolerant persister colorectal cancer cells that mediate relapse after chemotherapy

Published:2022-06-30 Issue:9 Volume:3 Page:1052-1070
ISSN:2662-1347
Container-title:Nature Cancer
language:en
Short-container-title:Nat Cancer

Author:

Álvarez-Varela Adrián,Novellasdemunt Laura^ORCID,Barriga Francisco M.^ORCID,Hernando-Momblona Xavier,Cañellas-Socias Adrià,Cano-Crespo Sara,Sevillano Marta,Cortina Carme,Stork Diana,Morral Clara,Turon Gemma,Slebe Felipe,Jiménez-Gracia Laura^ORCID,Caratù Ginevra,Jung Peter,Stassi Giorgio^ORCID,Heyn Holger^ORCID,Tauriello Daniele V. F.^ORCID,Mateo Lidia^ORCID,Tejpar Sabine,Sancho Elena^ORCID,Stephan-Otto Attolini Camille^ORCID,Batlle Eduard^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s43018-022-00402-0.pdf

Reference67 articles.

1. Van Cutsem, E., Cervantes, A., Nordlinger, B. & Arnold, D. The ESMO Guidelines Working Group. Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 25, iii1–iii9 (2014).

2. Argilés, G. et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31, 1291–1305 (2020).

3. Russo, M. et al. Adaptive mutability of colorectal cancers in response to targeted therapies. Science 366, 1473–1480 (2019).

4. Boumahdi, S. & de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. Nat. Rev. Drug Discov. 19, 39–56 (2020).

5. Shen, S., Vagner, S. & Robert, C. Persistent cancer cells: the deadly survivors. Cell 183, 860–874 (2020).

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Stem Cell markers: Symphonic masters of chemoresistance and immune evasion;Life Sciences;2024-10

2. CCDC113 promotes colorectal cancer tumorigenesis and metastasis via TGF-β signaling pathway;Cell Death & Disease;2024-09-11

3. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

4. Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response;International Immunopharmacology;2024-09

5. Global Scientific Trends in Organoids from 2004 to 2023: A Data-Driven Bibliometric and Visualized Analysis;2024-08-28